301239SZSE

Announcement on the Permanent Use of Part of the Overraised Funds to Supplement Working Capital

✨ AI Summary

The company plans to use RMB 24 million of overraised funds to permanently supplement its working capital, subject to shareholder approval. This decision follows the board's review on April 7, 2026, and aims to enhance liquidity and reduce financial costs. The total overraised funds amount to RMB 812.72 million, with the proposed use representing 29.53% of this total.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 301239
Securities Abbreviation: Puri Eye Hospital
Announcement Number: 2026-010

Announcement on the Permanent Use of Part of the Overraised Funds to Supplement Working Capital

Puri Eye Hospital Group Co., Ltd. (hereinafter referred to as "the Company") held the second meeting of the fourth board of directors on April 7, 2026, and reviewed and approved the proposal on the permanent use of part of the overraised funds to supplement working capital. The Company intends to use RMB 24 million of overraised funds for this purpose, which is subject to the review of the shareholders' meeting. The relevant situation is announced as follows:

1. Basic Situation of the Raised Funds

According to the approval from the China Securities Regulatory Commission (CSRC) regarding the registration of the initial public offering of shares by Chengdu Puri Eye Hospital Co., Ltd. (CSRC Permit [2022] No. 587), the Company issued 37,404,762 shares of RMB ordinary shares (A shares) with a par value of RMB 1.00 per share at an issuance price of RMB 33.65 per share, raising a total of RMB 1,258,670,241.30. After deducting issuance expenses (including tax), the actual net amount raised was RMB 1,098,935,692.69. Tianjian Accounting Firm (Special General Partnership) conducted an examination of the raised funds on June 27, 2022, and issued the verification report Tianjian Yan [2022] No. 314. The Company has opened a special account for the raised funds, stored the raised funds in a dedicated account, and signed a supervision agreement for the raised funds with the bank and the sponsor. All raised funds have been stored in the Company's special account as required.

2. Investment Projects of the Raised Funds

According to the investment projects and usage plan disclosed in the Company's prospectus for the initial public offering of shares and listing on the Growth Enterprise Market, the details are as follows:

No.Project NameProject Investment Amount (RMB)Amount of Raised Funds to be Invested (RMB)
1New Construction Project of Changchun Puri Eye Hospital74,204,500.0074,204,500.00
2Reconstruction Project of Harbin Puri Eye Hospital30,413,300.0030,413,300.00
3Information Management Construction Project101,593,600.00101,593,600.00
4Supplementing Working Capital Project80,000,000.0080,000,000.00
Total286,211,400.00286,211,400.00

The net amount of raised funds exceeds the investment amounts of the above projects, resulting in overraised funds of RMB 812,724,292.69 (after deducting issuance expenses).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.